SLASH-TB is a simple, data-driven tool that helps countries understand the health and economic benefits of adopting new TB treatments. Using real-world data, SLASH-TB estimates how newer, shorter regimens for drug-resistant TB can:

• Save money for health systems, patients, and families

• Improve treatment outcomes

• Reduce the overall burden of TB

The tool can be used at the country, regional, or hospital level, giving decision-makers fast, practical insights to support policy change, funding decisions, and implementation planning. By turning complex data into clear evidence, SLASH-TB helps governments and partners make informed choices—so that better TB treatments can reach more people, faster.